Many treatment options exist for Uterine Fibroids. Most treatments include unnecessary surgery which can come with painful and unwanted side effects. The Fibroid Treatment Collective focuses on nonsurgical Uterine Artery Embolization (UAE) treatment which is a non-invasive, out-patient procedure with high success rates and very few side effects.
Uterine Fibroid Embolization – Nonsurgical
Embolization has existed as a medical procedure since 1975. In gynecology it was used to reduce bleeding during uterine surgery. Founding members of the Fibroid Treatment Collective noticed another important effect. It shrank fibroids. The promise of an effective, non-invasive treatment led to research, trials and medical acceptance. Today more than several hundred thousand women world-wide have found relief with this safe, simple procedure. The Fibroid Treatment Collective performed the very first fibroid embolization in America in 1994 and has authored many important articles on the subject.
Hysterectomy – Surgical
Fibroids are the most common cause for hysterectomy, they are associated with as many as 40% of more than 600,000 hysterectomies performed in the US annually. Depending on their location, fibroids can cause either heavy bleeding, pelvic and back pain, or pressure on bowel and bladder. Most hysterectomies performed for fibroids [the medical term is myoma] are performed by the abdominal route since the fibroids may grow to be quite large. Fibroids are almost never cancerous.
Myomectomy – Surgical
Myomectomy is the surgical removal of fibroids from the uterus. There are three basic approaches. Abdominal myomectomy removes fibroids through an incision in the abdomen. Laparoscopic myomectomy uses several very small incisions in the abdomen to remove fibroids. Hysteroscopic Myomectomy requires an instrument called a resectoscope, which is inserted vaginally and uses electrical current to cut tissue. This type of myomectomy should only be performed by physicians trained in the use of a resectoscope.